Linoleic acid, glycemic control and type 2 diabetes

By 2050, an estimated one third of US adults will have type 2 diabetes mellitus (T2DM) [1]. Unfortunately, co-morbidities of T2DM include cardiovascular diseases, neuropathy, sleep apnea, blindness and depression, are all conditions that hasten mortality leading to 1 in 5 people dying as a result [1]. Pharmaceutical therapies for treating hyperglycemia in people with T2DM often have serious adverse side effects [2]. Lifestyle approaches offer alternative or complementary therapy to pharmaceutical treatment.

Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - April 6, 2018 Category: Biomedical Science Authors: Martha A. Belury, Rachel M. Cole, Deena B. Snoke, Taylor Banh, Austin Angelotti Source Type: research